LMAT – lemaitre vascular, inc. (US:NASDAQ)
Stock Stats
News
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value [Yahoo! Finance]
Do LeMaitre Vascular's (NASDAQ:LMAT) Earnings Warrant Your Attention? [Yahoo! Finance]
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Form 4 LEMAITRE VASCULAR INC For: Feb 05 Filed by: Roberts David B
Form 4 LEMAITRE VASCULAR INC For: Jan 08 Filed by: Kamke Trent G
Form SCHEDULE 13G/A LEMAITRE VASCULAR INC Filed by: Conestoga Capital Advisors, LLC
Form 4 LEMAITRE VASCULAR INC For: Dec 11 Filed by: LeMaitre George W
Form 4 LEMAITRE VASCULAR INC For: Dec 11 Filed by: Kamke Trent G
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.